Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting list of some patents to kill the time.
http://www.faqs.org/patents/assignee/ceres-inc/
Be nice if the company would release something positive soon while the spring is wound up. Problem is they are scientists and the worst at marketing themselves.
I am no expert, but there is something shifty going on for a long time.
You would have my vote for that!
Back at the launch pad. As you said, no changes yet.
As of June 1, 2015, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $9,238,284, based on 6,032,222 shares of outstanding common stock, of which approximately 4,237,745 shares were held by non-affiliates, and a per share price of $2.18 per share, which was the last reported sale price of our common stock on The Nasdaq Capital Market on June 1, 2015. We have not offered any securities pursuant to General Instruction I.B.6. of Form S-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus.
Back at the launch pad. As you said, no changes yet.
As of June 1, 2015, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $9,238,284, based on 6,032,222 shares of outstanding common stock, of which approximately 4,237,745 shares were held by non-affiliates, and a per share price of $2.18 per share, which was the last reported sale price of our common stock on The Nasdaq Capital Market on June 1, 2015. We have not offered any securities pursuant to General Instruction I.B.6. of Form S-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus.
All it would take is a new big name customer for Persephone and some grant/revenue info and it will run if you ask me.
They already said in early May this was coming so to me no surprise. I would guess all the players were ready as well. Hopefully good news is coming now to sell them into. Even still it is a low floater if you ask me.
Agree, feels like another push coming.
No doubt, seems to be the story of CERE.
The largest buyer of CERE at 9/30 last year has failed to update its holdings yet. I would love to see it what they have now
MARXE AUSTIN W & GREENHOUSE DAVID M
Definitely can, the low float is rocket fuel when it wants to be.
I am living dangerously with LL today while good old CERE settles out.
It is a buyer beware stock for sure. Learned it the hard way myself.
It did the same thing at the beginning of the month right before the S-3 was released and then it drifted back down under 2 and then popped yesterday on the news. Waiting to see what happens this time and to see if the offer is done.
It was listed as $8M in dollars I believe.
I can safely say, who knows if it will pop. That from experience. It may have taken that long to translate into something a common person would understand for all I know. Saw it on the 5th and had no real clue what it meant in the real world. All I know is that it was another piece of IP under their belt which is worth money at some point.
I am no expert, but keep in mind they are trying to get the S-3 shares in the market and it may have been related to that. These guys have some brilliant scientists working but it burns cash, however they may be at the turning point.
As always risky business.
Thanks, interesting to see it that way
So here is an interesting little tidbit. The patent was granted on the 5th with this PR on the GF network.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113459085
So why all of a sudden 22 days later they come out with the real PR and release. Things that make you go hmmmmm with our little gem.
Wonder if the delayed patent news will apply to the one on the 12th.
United States Patent 9,029,523
Alexandrov , et al. May 12, 2015
Promoter, promoter control elements, and combinations, and uses thereof
I wonder if the S-3 shares have all been put out in the market now. Nice pop to mix them in.
Pretty good exit point reached today if you got it where you said you did.
At least they announced one finally.
One of the main reasons I am still hanging in there, they haven't blinked yet
I planted some tomatoes in my backyard and so far they may bring in more money than my investment here will return.
Looks like we are back to sleepy time
So you may not be crazy. Check this one out, anyone know about them?
http://www.octafinance.com/ulys-top-5-13f-holdings-in-q1-2015/52338/
You get em?
Is the rocket ride over? Hard to believe they pumped the new shares in yet. One good thing is that Artal is still holding tight at 3/31
http://www.nasdaq.com/symbol/cere/institutional-holdings
Beat me to it, LOL. Just take out short term from the post and it sums it up.
Thanks for pointing it out, guess I missed it and that helps in a way. If they can get the price to 4 then it is only 2M shares I guess. If they could only make money then all would be a mute point.
I wonder if Artal got out on the run up since they along with the rest of us got hosed if you ask me. They just upped the share count 8x of what Artal, the biggest holder owned. I would have tried when it was at 3 plus and taken the hit but was not around when it did. ugh
One of the greatest in my book, IMO.
Or this new patent....
United States Patent 9,024,004
Alexandrov , et al. May 5, 2015
Sequence-determined DNA fragments encoding acetohydroxyacid synthase proteins
Abstract
The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3' termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait.
Inventors: Alexandrov; Nickolai (Thousand Oaks, CA), Brover; Vyacheslav (North Potomac, MD), Feldmann; Kenneth (Tucson, AZ)
Applicant:
Name City State Country Type
Ceres, Inc.
Thousand Oaks
CA
US
Assignee: Ceres, Inc. (Thousand Oaks, CA)
Family ID: 1000001076620
Appl. No.: 14/506,506
Filed: October 3, 2014
Tis interesting and with no float is could go vertical fast.
Below .20 now. Patience is getting hard to come by.
Pretty well sums it up.
http://seekingalpha.com/article/3080566-ceres-moving-beyond-bioenergy-could-be-a-case-of-too-little-too-late
Starting to lean on the tax loss vs cap gain outcome. :(
back to .23 pre RS pricing...there is some awesome news right there.
With the low nonexistent float they can't even pull of a run. Might be brilliant scientists, but sure are polar opposites when it comes to investing 101, mastered the dump phase but not the pump phase
So should we be buying more to average down since they are being so kind in providing cheaper shares by the day?
If there was a "Like" button I would press it. LOL
I don't get it either. Either there is some high test Kool Aid being passed around when they meet or there is something bigger going on that is being so well hidden that the black helicopters can't even see. I guess the point of no cash is coming and that aught to flush it out one way or another. Very puzzled myself. Also bothers me that the one hedge fund that bought in big in 3Q last year hasn't filed anything for the 4Q 2014 holdings which is strange, at least to me.
I'm in it at around 7 bucks now so a ways to go for me/
Status: Confused but not dazed.
Oh gee, another patent..guess patents are a non event with CERE. Most other companies might, just might want to inform investors and others.
United States Patent 9,000,140
Alexandrov , et al. April 7, 2015
Sequence-determined DNA fragments encoding AN1-like zinc finger proteins
Abstract
The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3' termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait.
I am guessing they want to drive everyone out now that they took all the IPO money and everything else from the secondary and take it private now that they are getting close. Just my opinion and at this point who knows what will happen. Even the analysts have left the room. They have a lot of IP and tech and there is no rational reason other than poor management that we are where we are at if you wanted my opinion.